RPL21P135

Across TCGA pan-cancer cohorts, RPL21P135 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RPL21P135 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RPL21P135 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPL21P135 expression acts as an unfavorable survival marker, although some lineages such as UCS and SKCM show a favorable association.

UCS, SKCM, and BLCA are the cancer types where RPL21P135 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.566	0.186	.005	40	view →
SKCM	OS	Quartile	All	0.812	0.684	.003	32	view →
BLCA	OS	Tertile	All	0.679	0.426	.007	28	view →
KIRP	OS	Tertile	All	1.000	0.536	.003	26	view →
LUAD	OS	Median	II,III,IV	0.365	0.127	.008	26	view →
CHOL	OS	Tertile	All	0.337	0.851	.007	15	view →
ACC	OS	Quartile	II,III,IV	0.678	0.932	.014	13	view →
READ	DFS	Median	IV	0.374	0.845	.002	12	view →
LGG	DFS	Median	All	0.570	0.373	.005	8	view →
LIHC	DFS	Quartile	All	0.230	0.380	.035	7	view →
HNSC	DFS	Tertile	III,IV	0.666	0.433	.032	6	view →
UVM	DFS	Tertile	III,IV	0.463	0.828	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RPL21P135–UCS (OS)

Open the UCS breakdown →